Related Experiment Video
Updated: May 28, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
A Non-Canonical Role of SMAD4 in Regulating 3D Genome Architecture to Inhibit Lung Squamous Cell Carcinoma
Qian Tang1,2, Chen Lian1, Xinyan Han1,2
1Department of Respiratory and Critical Care Medicine, The Second Affiliated Hospital, and Zhejiang University-University of Edinburgh Institute (ZJU-UoE Institute), Zhejiang University School of Medicine, Zhejiang University, Haining, China.
Abstract:
Lung squamous cell carcinoma (LUSC) lacks clearly defined key drivers and effective targeted therapies, reflecting an incomplete understanding of its molecular pathogenesis. Here, we identify SMAD4 as a critical regulator of three-dimensional (3D) genome organization in LUSC and uncover a mechanistic link between tumor suppressor loss and oncogenic transcriptional activation. By integrating clinical datasets, genetically engineered mouse models, human and murine LUSC cell lines, and multi-omics analyses, we demonstrate that SMAD4 deficiency promotes LUSC progression by unleashing EP300-mediated enhancer-promoter looping at the SOX2 locus. Mechanistically, SMAD4 does not directly bind SOX2 regulatory elements but instead constrains chromatin looping by sequestering EP300 away from loop anchor regions. Loss of SMAD4 leads to enhanced H3K27ac deposition, aberrant SOX2 activation, and increased LUSC tumor cell proliferation. Together, these findings reveal a non-canonical role for a transcription factor (e.g., SMAD4) in regulating dysregulated 3D genome architecture to inhibit tumor development.
Insights
SMAD4 loss in lung squamous cell carcinoma (LUSC) disrupts 3D genome organization, activating SOX2 and promoting tumor growth. This reveals a new therapeutic target for LUSC.
Area of Science:
- Oncology
- Molecular Biology
- Genomics
Background:
- Lung squamous cell carcinoma (LUSC) lacks defined drivers and targeted therapies.
- Understanding LUSC molecular pathogenesis is incomplete.
Purpose of the Study:
- Identify key regulators of LUSC 3D genome organization.
- Elucidate the link between tumor suppressor loss and oncogenic transcriptional activation in LUSC.
Main Methods:
- Integrated clinical datasets, genetically engineered mouse models, and LUSC cell lines.
- Performed multi-omics analyses to study genome organization and gene regulation.
- Investigated the role of SMAD4 and EP300 in enhancer-promoter looping at the SOX2 locus.
Main Results:
- SMAD4 deficiency promotes LUSC progression by enabling EP300-mediated enhancer-promoter looping at the SOX2 locus.
- SMAD4 constrains chromatin looping by sequestering EP300, and its loss leads to aberrant SOX2 activation.
- SMAD4 loss increases H3K27ac deposition and LUSC tumor cell proliferation.
Conclusions:
- SMAD4 is a critical regulator of 3D genome organization in LUSC.
- SMAD4 loss drives LUSC through dysregulated 3D genome architecture and SOX2 activation.
- Targeting SMAD4 or its downstream effects presents a potential therapeutic strategy for LUSC.
Related Concept Videos
TGF - β Signaling Pathway
Abnormal Proliferation
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
The JAK-STAT Signaling Pathway
Inhibition of Cdk Activity
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...

